PINK ETF Analysis: Simplify Exchange Traded | NYSE
Health | NYSE, USA | Market Cap: 296m USD | 12M Return: 29.2% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 3.71M
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 4.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
The Simplify Health Care ETF (PINK) is a U.S.-listed exchange-traded fund that invests at least 80% of its assets in securities of American health care companies. The fund relies on the Global Industry Classification Standard (GICS) to define its eligible universe, which spans sub-industries such as pharmaceuticals, biotechnology, medical devices, and health care providers and services.
Under normal market conditions, the portfolio holds between 50 and 100 health care companies. The adviser focuses on two general themes: firms developing new and effective medicines, and companies whose business models are designed to lower costs or improve quality within health care systems.
Launched in October 2021 with a micro-cap profile, the fund provides diversified, sector-specific exposure to U.S. health care equities through a single ticker, a common structural feature of thematic ETFs.
- Drug pricing reforms pressure pharma profit margins
- Biotech innovation and FDA approvals drive ETF returns
- Aging demographics sustain long-term healthcare demand growth
As of July 24, 2026, the stock is trading at USD 38.68 with a total of 82,884 shares traded. Over the past week, the price has changed by -0.67%, over one month by +2.87%, over three months by +10.03% and over the past year by +29.23%.
Current recommended Stop Loss: 37.80 (which is 2.3% or 1.3 ATR below the current price).
Simplify Exchange Traded has no consensus analysts rating.